期刊文献+

连续性血液滤过在顽固性心力衰竭中的应用 被引量:5

Application of continuing hemofiltration in patients with refratory heart failure
下载PDF
导出
摘要 目的探索连续性静脉-静脉血液滤过(CVVH)对顽固性心力衰竭的治疗效果。方法将40例经内科药物保守治疗效果不佳的顽固性心力衰竭患者分为观察组(22例),对照组(18例),观察组予以CVVH治疗,对照组予以保守治疗;观察治疗前后心功能、血液生化、细胞因子浓度以及两组患者28 d死亡率。结果CVVH可明显改善患者的心功能、纠正代谢紊乱,降低炎症细胞因子水平,28 d死亡率由对照组的94.4%降至45.5%(P<0.05)。结论CVVH对顽固性心力衰竭患者是一种迅速而有效的治疗方法,能在短期内缓解临床症状,阻断疾病的恶性循环,为进一步治疗赢得宝贵的时间。 Objective To explore the therapeutic effect of continuous venovenous hemofihration(CVVH) for refractory heart failure. Methods 40 patients with refractory heartfailure were derided into two groups : observation group(22 cases)and control group (18 cases). Observation group received CVVH, control group received medical treatment. Cardiac function ,changes of blood biochemistry,cytokine concentration and 28 days mortality were investigated before and after continuous venovenous hemofiltration in patients. Results Compared with control group, the mortality rate decreased (94.5 % vs 45.5 %, P 〈 0.05 ), and heart function and metabolic disturbance inproved, and seram inflammetory cytolcines decreased significanty in observation group during the 28 day treatment period. Conclu. sion Continuous venovenous hemofihration could be a rapid and effective method in treating patients with refractory heart failure.
出处 《中国临床保健杂志》 CAS 2010年第1期59-61,共3页 Chinese Journal of Clinical Healthcare
关键词 心力衰竭 血液滤过 细胞因子类 Heart failure Hemofihration Cytokines
  • 相关文献

参考文献11

  • 1陈灏珠,戴自英,林果为,等.实用内科学[M].12版.北京:人民卫生出版社,2005.1333—1336.
  • 2Blum A, Miller H. Role of cytokines in heart failure [ J ]. Am Heart,1998,135(2 pt 1) :181-186.
  • 3Vadlamani L, Abraham WT. Insight into pathogenesis and treatment of cytokines in cardiomyopathy [ J ]. Currcatdid Rep,2000,2 (2) :120-128.
  • 4HosenpudJD,GreenbergBH.充血性心力衰竭-病理生理、诊断和治疗[M].陈新,江洪,译.2版.北京:科学出版社,2004:217-223.
  • 5贺泽龙,郭振球.参附液和参麦液对实验性心衰大鼠血流动力学和心肌β受体影响的比较研究[J].中国中医基础医学杂志,2003,9(5):36-38. 被引量:57
  • 6Sasayama AM, Matsumori A, Kihara Y. New insights into the pathophysiological role for cytokines in heart failure [ J ]. Cardiovasc ResL, 1999,42 (3) :537-564.
  • 7Kadokami T, Frye C, Lemster B, et al. Anti-tumor necrosis factor-alphe antibody limits heart failure in a transgenic model[ J]. Circulations ,2001,104(10) : 1094-1097.
  • 8Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure[J]. Annu Rev Mde,2001,52:15.
  • 9Robert OB . Management of cardiovascular-renal complication. Criculation ,2002,105 ( 1 ) : 159-164.
  • 10Bellomo R, Ronco C. The Kidney in heart failure [ J ]. Kidney Int, 1998, (9) :58.

二级参考文献10

共引文献540

同被引文献43

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部